News

The three-year collaboration is designed to discover and develop proprietary siRNA molecules against up to five specific targets provided by AstraZeneca. Under terms of the agreement, Silence Therapeutics

Tibotec Pharmaceuticals, a division of Johnson & Johnson, manufactures the drugs which are called etravirine (TMC125) and darunavir (TMC114). The studies examined the use of TMC125 in combination

The warning informed doctors that cases of fatal reactions in the lungs and kidneys in both term and premature babies had been found when the drug was administered

Under the agreement, Granules will develop and register selected products for US ANDA submission, and will receive up front and milestone payments. Heritage will retain exclusive sales and

The team, led by Karl Deisseroth, assistant professor of bioengineering and of psychiatry and behavioral sciences, found that in rats the differing mechanisms of depression and its treatment

Currently, Seasonale is marketed in the US where it was launched in October 2003 by Barr Laboratories’ subsidiary, Duramed Pharmaceuticals. In October 2005 Duramed granted Paladin an exclusive

Roche is filing a formal complaint against the US firm’s “poison-pill” defense provision to issue new shares at half price to its shareholders if Roche buys 20% of

According to the company, there are currently few proven treatment options available to patients with breast cancer whose disease has rapidly progressed through or is not responding to

The compound, MIV-170, did not meet the profile desired by Bristol-Myers Squibb, according to the company. MIV-170 belongs to a group of polymerase inhibitors that Medivir’s subsidiary, Medivir